| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 11 | +63.64% | +2.26% | -0.23% | +2.49% | -1.98% | — |
| 14d | 11 | +36.36% | +1.88% | +0.45% | +1.43% | +1.32% | — |
| 30d | 11 | +54.55% | -0.58% | +0.04% | -0.62% | +1.68% | — |
| 60d | 11 | +72.73% | -2.06% | -1.66% | -0.40% | -1.46% | — |
| 90d | 11 | +45.45% | -2.25% | +1.82% | -4.06% | +3.70% | — |
| 180d | 11(3 pending) | +75.00% | -2.75% | +7.25% | -10.00% | -23.86% | — |
| 1y | 11(5 pending) | +50.00% | -17.18% | +18.27% | -35.44% | -32.31% | — |
| 2y | 11(8 pending) | +66.67% | -36.95% | +46.19% | -83.14% | -100.58% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KURA KURA ONCOLOGY, INC. | SALE10b5-1 10b5-1 plan | 2,256 | $9.38 | $21.2K | 226,931 | May 18, 2026 | May 20, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE Chief Legal Officer | 2,335 | $8.46 | $19.8K | 231,708 | Jan 27, 2026 | Jan 27, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE Chief Legal Officer | 4,096 | $8.46 | $34.7K | 234,043 | Jan 27, 2026 | Jan 27, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE Chief Legal Officer | 4,777 | $8.46 | $40.4K | 226,931 | Jan 27, 2026 | Jan 27, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 238,139 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE10b5-1 10b5-1 plan | 8,804 | $11.18 | $98.4K | 188,139 | Nov 14, 2025 | Nov 14, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 48,900 | — | — | 196,943 | Nov 13, 2025 | Nov 14, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE10b5-1 10b5-1 plan | 8,805 | $8.94 | $78.7K | 148,043 | Sep 29, 2025 | Sep 29, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 48,900 | — | — | 156,848 | Sep 27, 2025 | Sep 29, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE10b5-1 10b5-1 plan | 1,559 | $5.96 | $9.3K | 107,948 | May 19, 2025 | May 19, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE Chief Legal Officer | 2,437 | $7.87 | $19.2K | 112,792 | Jan 28, 2025 | Jan 28, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE Chief Legal Officer | 4,844 | $7.87 | $38.1K | 107,948 | Jan 28, 2025 | Jan 28, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 46,250 | — | — | 115,229 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 92,500 | — | — | 92,500 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE10b5-1 10b5-1 plan | 2,615 | $22.15 | $57.9K | 68,979 | May 20, 2024 | May 20, 2024 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE Chief Legal Officer | 2,053 | $17.80 | $36.5K | 68,979 | Jan 29, 2024 | Jan 31, 2024 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 92,500 | — | — | 92,500 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 46,250 | — | — | 71,032 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 23,125 | — | — | 23,125 | Feb 16, 2023 | Feb 21, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 138,750 | — | — | 138,750 | Feb 16, 2023 | Feb 21, 2023 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | SALE Chief Legal Officer | 2,100 | $15.22 | $32.0K | 0 | Nov 17, 2022 | Nov 18, 2022 ↗ | View → |
| KURA KURA ONCOLOGY, INC. | PURCHASEGRANT Stock grant | 192,000 | — | — | 192,000 | Oct 18, 2021 | Oct 19, 2021 ↗ | View → |